🇺🇸 US

IBRX earnings report dates and EPS history (Immunitybio, Inc.)

Quick answer

Immunitybio, Inc. (IBRX) reported diluted EPS of $-0.22 for the quarter ended 2026-06-30, in a 10-Q filed with the SEC on 2026-08-04. Its last four 10-Q/10-K filings were on 2026-08-04, 2026-05-07, 2026-02-23, 2025-11-05.

✓ SEC EDGAR XBRL company facts (10-K/10-Q filings)

Data as of 2026-08-04. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)

Period endPeriodFormSEC filing dateDiluted EPS
2026-06-30Quarter10-Q2026-08-04$-0.22
2026-03-31Quarter10-Q2026-05-07$-0.62
2025-12-31Full year10-K2026-02-23$-0.38
2025-09-30Quarter10-Q2025-11-05$-0.07
2025-06-30Quarter10-Q2025-08-05$-0.10
2025-03-31Quarter10-Q2025-05-12$-0.15
2024-12-31Full year10-K2025-03-03$-0.62
2024-09-30Quarter10-Q2024-11-12$-0.14
2024-06-30Quarter10-Q2024-08-12$-0.20
2024-03-31Quarter10-Q2024-05-09$-0.20
2023-12-31Full year10-K2024-03-19$-1.15
2023-09-30Quarter10-Q2023-11-09$-0.19
2023-06-30Quarter10-Q2023-08-08$-0.32
2023-03-31Quarter10-Q2023-05-11$-0.27
2022-12-31Full year10-K2023-03-01$-1.04
2022-09-30Quarter10-Q2022-11-09$-0.28

Related

Last updated 2026-10-16. Data only, not financial or tax advice.